The 25% reduction in the price of pretomanid could save Global Drug Facility clients upwards of $3 million a year.
The battery-powered device is the first to detect Mycobacterium tuberculosis in saliva in addition to blood and sputum.
Other trends included worrisome rises in tuberculosis, measles, and pertussis.
In the wake of US funding cuts, the WHO is urging global health leaders, donors, and policymakers to protect and maintain TB support and care services.
Malaria, HIV, and TB programs are already feeling impacts from the cuts, with scale-backs also depleting healthcare services in Afghanistan.
The trial is evaluating the safety and efficacy of MTBVAC, a single shot, live-attenuated TB vaccine, in people with latent TB in 3 countries.
Of children aged 5 to 10 years, about 40% had abnormal lung function post-treatment, rising to 65% in older children.
In a study in Belarus and Uzbekistan, 96% of patients with drug-resistant TB who received the regimens had successful treatment outcomes.
The 90-day funding freeze, and the subsequent dismantling of USAID, has sent shockwaves throughout the community of people working on TB diagnosis, treatment, and prevention.
The global research agenda includes 33 research priorities for bacterial and fungal infections and 7 for drug-resistant tuberculosis.
